Back

Clonal hematopoiesis of indeterminate potential (CHIP) is associated with increased risk of diastolic dysfunction in a cardio-oncology cohort

30 August 2026 (14:30 - 14:42)
Organised by: Logo
Congress Presentation Part of: Predicting and preventing cancer therapy–related cardiac dysfunction: from artificial intelligence to cardiometabolic protection Cardio-Oncology ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Jaiveer Singh

(United States of America)

3 More presentations in this session

Presentation thumbnail
Artificial intelligence–enabled electrocardiography as a pre-treatment predictor of chemotherapy-related cardiac dysfunction
Doctor M. Lee (Bucheon, KR)
Abstract Slides Video
Presentation thumbnail
GLP-1 receptor agonists for anthracycline-associated cardiac outcomes: first meta-analytic evaluation in propensity-matched cohorts
Mr A. Chauhan (IN)
Abstract Slides Video
Presentation thumbnail
Stratification of cancer-therapy related cardiac dysfunction: a validated prediction tool to identify low risk patients.
Doctor J. Gonzalez Juanatey (Santiago de Compostela, ES)
Abstract Slides

Access the full session

Session thumbnail
Predicting and preventing cancer therapy–related cardiac dysfunction: from artificial intelligence to cardiometabolic protection
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 14:30 CET
You may be interested in
thumbnail
Congress Presentation
Clonal hematopoiesis of indeterminate potential in cardiovascular disease: from atherosclerosis to heart failure - discussion
17 May 2025
thumbnail
Congress Session
Daily cardiac problems in cancer patients
31 August 2024
thumbnail
Congress Presentation
Clonal haematopoiesis of indeterminate potential and incident cardiomyopathy
30 August 2025
thumbnail
Congress Presentation
Clonal hematopoiesis and left atrial remodeling in the young: a UK biobank cardiac MRI study
30 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources